We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+19.34%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$2.98B
AUM Growth
+$183M
Cap. Flow
-$56M
Cap. Flow %
-1.88%
Top 10 Hldgs %
40.77%
Holding
386
New
143
Increased
26
Reduced
89
Closed
78

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$335M
2
CYBR
CyberArk
CYBR
+$146M
3
MRUS
Merus
MRUS
+$105M
4
WNS
WNS Holdings
WNS
+$72.5M
5
VBTX
Veritex Holdings
VBTX
+$72.4M

Top Sells

Rank Stock Value
1
ESGR
Enstar Group
ESGR
+$243M
2
SWTX
SpringWorks Therapeutics
SWTX
+$193M
3
BPMC
Blueprint Medicines
BPMC
+$171M
4
DNB
Dun & Bradstreet
DNB
+$162M
5
SKX
Skechers
SKX
+$151M

Sector Composition

Rank Sector Weight
1 Financials 33.45%
2 Healthcare 25.15%
3 Technology 17.6%
4 Consumer Discretionary 2.62%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FACTW
276
FACT II Acquisition Corp Warrant
FACTW
$1.75M
$11K ﹤0.01%
38,300
-59,814
-61% -$15.7K
DTSQU
277
DT Cloud Star Acquisition Corp Units
DTSQU
$10K ﹤0.01%
991
– –
MTSR
278
PUT
DELISTED
Metsera Inc
MTSR
$10K ﹤0.01%
+243
New +$8.97K
RFAIR
279
RF Acquisition Corp II Right
RFAIR
$8K ﹤0.01%
100,000
-321,387
-76% -$25.7K
RDACR
280
Rising Dragon Acquisition Corp Rights
RDACR
$8K ﹤0.01%
50,000
-108,994
-69% -$19K
TAVIR
281
Tavia Acquisition Corp Right
TAVIR
$8K ﹤0.01%
39,569
-58,380
-60% -$11.5K
TDACW
282
Translational Development Acquisition Corp Warrants
TDACW
$15.4M
$7K ﹤0.01%
23,900
-26,100
-52% -$7.07K
FVNNU
283
Future Vision II Acquisition Corp Units
FVNNU
$59.7M
$7K ﹤0.01%
672
– –
LWACU
284
LightWave Acquisition Corp Units
LWACU
$6K ﹤0.01%
582
-289,418
-100% -$2.91M
LPBBU
285
Launch Two Acquisition Corp Unit
LPBBU
$217M
$4K ﹤0.01%
385
– –
FTW.U
286
DELISTED
EQV Ventures Acquisition Corp Units
FTW.U
$3K ﹤0.01%
295
+195
+195% +$2.09K
LEGT.U
287
DELISTED
Legato Merger Corp III Units
LEGT.U
$2K ﹤0.01%
+140
New +$1.54K
STAA icon
288
PUT
STAAR Surgical
STAA
$1.21B
$1K ﹤0.01%
+15
New +$358
BACQU
289
DELISTED
Inflection Point Acquisition Corp IV Unit
BACQU
$1K ﹤0.01%
100
– –
DAAQW
290
Digital Asset Acquisition Corp Warrant
DAAQW
$2.59M
$1K ﹤0.01%
2,645
-96,453
-97% -$76.5K
LCCCR
291
Lakeshore Acquisition III Corp Rights
LCCCR
$1K ﹤0.01%
6,731
-197,709
-97% -$42K
AFJKR
292
Aimei Health Technology Co Right
AFJKR
– –
-38,931
Closed -$9K
AGS
293
DELISTED
PlayAGS
AGS
– –
-3,451,287
Closed -$43.1M
AMED
294
DELISTED
Amedisys
AMED
– –
-44,669
Closed -$4.39M
ANSCU
295
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
$0 ﹤0.01%
5
– –
AMCI
296
AMC Robotics
AMCI
$107M
– –
-80,013
Closed -$941K
AZEK
297
DELISTED
The AZEK Co
AZEK
– –
-1,706,849
Closed -$92.6M
BPMC
298
DELISTED
Blueprint Medicines
BPMC
– –
-1,331,300
Closed -$171M
BRDG
299
DELISTED
Bridge Investment Group
BRDG
– –
-1,136,733
Closed -$11.4M
CHX
300
DELISTED
ChampionX
CHX
– –
-2,464,373
Closed -$61.2M
10 11
12
13 14

Similar funds

GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return

Glazer Capital LLC's Q3 2025 Portfolio in Review

As of Q3 2025, Glazer Capital LLC held 386 positions worth $2.98B, up 6.5% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Glazer Capital LLC's Q3 2025 filing shows 143 new, 26 increased, 89 reduced and 78 closed positions. Its largest new stake was Verona Pharma: 3,205,878 shares worth $342M. The largest sale was Enstar Group, an estimated $243M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Technology.

  • Glazer Capital LLC's largest Q3 2025 buy was Verona Pharma: 3,205,878 shares worth $342M.
  • Glazer Capital LLC added most to Mr. Cooper in Q3 2025, an estimated $61.6M increase.
  • Glazer Capital LLC's biggest Q3 2025 reduction was Dynamix Corp, cutting an estimated $8.17M.
  • Glazer Capital LLC fully exited Enstar Group in Q3 2025, selling an estimated $243M.
  • Glazer Capital LLC's ten largest holdings make up 41% of its $2.98B portfolio in Q3 2025.
  • Glazer Capital LLC opened 143 new positions and closed 78 in Q3 2025.
  • Glazer Capital LLC's portfolio value rose 6.5% quarter-over-quarter to $2.98B.

Based on Glazer Capital LLC's 13F filing for Q3 2025, filed 13 Nov 2025.